Canon U.S.A. Announces New Company: Canon BioMedical, Inc.
The New Subsidiary Will Serve as Worldwide Headquarters For Life Science and Healthcare Businesses
MELVILLE, N.Y., March 2, 2015 – Canon U.S.A., Inc., a leader in digital imaging solutions, today announced the establishment of Canon BioMedical, Inc., a new wholly owned subsidiary that will serve as a worldwide headquarters for its biomedical business. The new company will conduct development, manufacturing and marketing operations relating to Canon’s life science and molecular diagnostics platform and seek to expand the use of Canon technology into other medical fields.
Based in Melville, New York, Canon BioMedical will be under the leadership of President and CEO, Ms. Akiko Tanaka. The new company will look for long-term future growth opportunities in previously untapped markets for Canon such as life science, healthcare, and medical analysis through the use of existing and emerging Canon technology, as well as strategic partnerships.
“We are truly excited and proud to launch Canon BioMedical, Inc., an American-born worldwide headquarters committed to bringing to market innovative technologies and solutions,” said Joe Adachi, chairman and CEO, Canon U.S.A., Inc. “We look forward to bringing Canon technology to clinicians and scientists all over the world in an effort to assist in improving human health and in advancing science.”
For further media inquiries, please contact firstname.lastname@example.org.